Synapse Open Synapse
Biology

Verastem cancer drug shows early promise in small study

BioPharma Dive · · 2 min read

Wall Street analysts believe Verastem’s drug to now be “competitive” in what’s quickly become one of the most active and crowded areas of oncology research.

Latest from BioPharma Dive